Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes
Authors
Keywords
-
Journal
Bioanalysis
Volume 6, Issue 3, Pages 293-306
Publisher
Future Science, LTD
Online
2014-01-29
DOI
10.4155/bio.13.286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Capillary microsampling in the regulatory environment: validation and use of bioanalytical capillary microsampling methods
- (2013) Lars B Nilsson et al. Bioanalysis
- An Alternative Approach for Quantitative Bioanalysis using Diluted Blood to Profile Oral Exposure of Small Molecule Anticancer Drugs in Mice
- (2012) Bianca M. Liederer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Capillary microsampling of 25 µl blood for the determination of toxicokinetic parameters in regulatory studies in animals
- (2012) Ove Jonsson et al. Bioanalysis
- Updates from the EBF DBS–microsampling consortium
- (2012) Philip Timmerman et al. Bioanalysis
- Validation of a bioanalytical method using capillary microsampling of 8 µl plasma samples: application to a toxicokinetic study in mice
- (2012) Ove Jonsson et al. Bioanalysis
- In vivo solid-phase microextraction for monitoring intravenous concentrations of drugs and metabolites
- (2011) Heather L Lord et al. Nature Protocols
- Evaluation of blood microsampling techniques and sampling sites for the analysis of drugs by HPLC–MS
- (2011) Christopher Smith et al. Bioanalysis
- High-throughput polymer monolith in-tip SPME fiber preparation and application in drug analysis
- (2011) Wei Xie et al. Bioanalysis
- EBF and dried blood spots: from recommendations to potential resolution
- (2011) Philip Timmerman et al. Bioanalysis
- Use of Dried Blood Spots in Drug Development: Pharmacokinetic Considerations
- (2010) Malcolm Rowland et al. AAPS Journal
- In vivo solid-phase microextraction for single rodent pharmacokinetics studies of carbamazepine and carbamazepine-10,11-epoxide in mice
- (2010) Dajana Vuckovic et al. JOURNAL OF CHROMATOGRAPHY A
- The use of human plasma as matrix for calibration standards in pre-clinical LC–MS/MS methods—A way to reduce animal use
- (2010) Britt-Marie Jacobson et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods
- (2010) Paul Abu-Rabie et al. Bioanalysis
- Sensitive determination of a drug candidate in dried blood spots using a TLC–MS interface integrated into a column-switching LC–MS/MS system
- (2010) Katja Heinig et al. Bioanalysis
- Pharmacokinetic considerations as to when to use dried blood spot sampling
- (2010) Gary Emmons et al. Bioanalysis
- Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies
- (2008) Matt Barfield et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Improved Pharmacokinetic and Bioavailability Support of Drug Discovery Using Serial Blood Sampling in Mice
- (2008) Sean X. Peng et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started